eCite Digital Repository
Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1
Citation
Burgess, JR and Giles, N and Shepherd, JJ, Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1, Clinical Endocrinology, 55, (5) pp. 689-693. ISSN 0300-0664 (2001) [Refereed Article]
DOI: doi:10.1046/j.1365-2265.2001.01348.x
Abstract
Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant tumour syndrome. It is characterized by primary hyperparathyroidism, pituitary neoplasia and foregut lineage neuroendocrine neo-plasia. Malignant thymic carcinoid tumours are an uncommon but important manifestation of MEN 1. Transcervical thymectomy is often advocated as prophylaxis against thymic carcinoids, although there is a paucity of evidence to support the efficacy of this procedure. This is the first report of a malignant thymic carcinoid occurring in an MEN 1 patient following prior parathyroidectomy and transcervical thymectomy. It is concluded that transcervical thymectomy does not reliably provide prophylaxis against thymic carcinoid.
Item Details
Item Type: | Refereed Article |
---|---|
Research Division: | Biomedical and Clinical Sciences |
Research Group: | Oncology and carcinogenesis |
Research Field: | Oncology and carcinogenesis not elsewhere classified |
Objective Division: | Health |
Objective Group: | Clinical health |
Objective Field: | Clinical health not elsewhere classified |
UTAS Author: | Burgess, JR (Professor John Burgess) |
UTAS Author: | Shepherd, JJ (Professor Joseph Shepherd) |
ID Code: | 21786 |
Year Published: | 2001 |
Web of Science® Times Cited: | 33 |
Deposited By: | Medicine |
Deposited On: | 2001-08-01 |
Last Modified: | 2011-09-29 |
Downloads: | 0 |
Repository Staff Only: item control page